Clinical Trial Update: Genomics of In-Stent Restenosis

View source ↗

Summary

An NHLBI-sponsored genomics study on in-stent restenosis, a vascular disease, has completed and the update summarizes the research.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• In-stent Restenosis
• Vascular Disease

Snippet

Sponsor: National Heart, Lung, and Blood Institute (NHLBI) | Conditions: In-Stent Restenosis, Vascular Disease | Status: COMPLETED